Skip to main content
. 2018 Oct;10(Suppl 29):S3528–S3532. doi: 10.21037/jtd.2018.04.104

Figure 2.

Figure 2

(A) Lung NETs OS curve and (B) CIR curve according to their different histologies. NETs, neuroendocrine tumors; OS, overall survival; CIR, cumulative incidence of recurrence; SCLC, small-cell lung cancer; LCNC, large-cell neuroendocrine carcinoma.